Anti-DGKE/ AHUS7/ DAGK5 monoclonal antibody

Anti-DGKE/ AHUS7/ DAGK5 antibody for FACS & in-vivo assay

Target products collectionGo to DGKE/DGKE products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0358-Ab-1/ GM-Tg-hg-MP0358-Ab-2Anti-Human DGKE monoclonal antibodyHuman
GM-Tg-rg-MP0358-Ab-1/ GM-Tg-rg-MP0358-Ab-2Anti-Rat DGKE monoclonal antibodyRat
GM-Tg-mg-MP0358-Ab-1/ GM-Tg-mg-MP0358-Ab-2Anti-Mouse DGKE monoclonal antibodyMouse
GM-Tg-cynog-MP0358-Ab-1/ GM-Tg-cynog-MP0358-Ab-2Anti-Cynomolgus/ Rhesus macaque DGKE monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0358-Ab-1/ GM-Tg-felg-MP0358-Ab-2Anti-Feline DGKE monoclonal antibodyFeline
GM-Tg-cang-MP0358-Ab-1/ GM-Tg-cang-MP0358-Ab-2Anti-Canine DGKE monoclonal antibodyCanine
GM-Tg-bovg-MP0358-Ab-1/ GM-Tg-bovg-MP0358-Ab-2Anti-Bovine DGKE monoclonal antibodyBovine
GM-Tg-equg-MP0358-Ab-1/ GM-Tg-equg-MP0358-Ab-2Anti-Equine DGKE monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0358-Ab-1/ GM-Tg-hg-MP0358-Ab-2; GM-Tg-rg-MP0358-Ab-1/ GM-Tg-rg-MP0358-Ab-2;
GM-Tg-mg-MP0358-Ab-1/ GM-Tg-mg-MP0358-Ab-2; GM-Tg-cynog-MP0358-Ab-1/ GM-Tg-cynog-MP0358-Ab-2;
GM-Tg-felg-MP0358-Ab-1/ GM-Tg-felg-MP0358-Ab-2; GM-Tg-cang-MP0358-Ab-1/ GM-Tg-cang-MP0358-Ab-2;
GM-Tg-bovg-MP0358-Ab-1/ GM-Tg-bovg-MP0358-Ab-2; GM-Tg-equg-MP0358-Ab-1/ GM-Tg-equg-MP0358-Ab-2
Products NameAnti-DGKE monoclonal antibody
Formatmab
Target NameDGKE
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-DGKE benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species DGKE/ AHUS7/ DAGK5 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLPm004253mouse Dgke Lentivirus plasmid
    ORF Viral VectorvGMLPm004253mouse Dgke Lentivirus particle


    Target information

    Target IDGM-MP0358
    Target NameDGKE
    Gene ID8526,56077,497978,712450,491102,101101267,538147,100056676
    Gene Symbol and SynonymsAHUS7,DAGK5,DAGK6,DGK,DGK-epsilon,DGKE,NPHS7
    Uniprot AccessionP52429
    Uniprot Entry NameDGKE_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000153933
    Target ClassificationN/A

    The target: DGKE, gene name: DGKE, also named as AHUS7, DAGK5, DAGK6, DGK, NPHS7. Diacylglycerol kinases are thought to be involved mainly in the regeneration of phosphatidylinositol (PI) from diacylglycerol in the PI-cycle during cell signal transduction.  When expressed in mammalian cells, DGK-epsilon shows specificity for arachidonyl-containing diacylglycerol. DGK-epsilon is expressed predominantly in testis. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.